Clinical trial
Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic…
NCT00296023 · University of California, San Francisco, Other · Completed
Key facts
| NCT number | NCT00296023 |
|---|---|
| Title | Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer |
| Official title | Low-Dose Allogeneic Peripheral Blood Stem Cell Transplantation for High-Risk Low Grade Hematologic Malignancies |
| Lead sponsor | University of California, San Francisco, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes |
| Intervention type | Biological, Drug, Procedure |
| Interventions | anti-thymocyte globulin, filgrastim, therapeutic allogeneic lymphocytes, busulfan, fludarabine phosphate, methotrexate, tacrolimus, nonmyeloablative allogeneic hematopoietic stem cell transplantation, peripheral blood stem cell transplantation |
| Enrollment | 25 |
| Start date | Jan 1, 1999 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2008 |
| First posted | Feb 24, 2006 |
| Last update posted | Oct 4, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: